Lucanthone, a novel autophagic inhibitor, induces apoptosis via cathepsin D accumulation and enhances histone deacetylase inhibitor (vorinostat)-induced cell death in MDA-MB-231 breast cancer cells [3]. Here, CTSD is linked to breast carcinoma.